LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Long-term Receivables, Current
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Long-term Receivables, Current of $400.00 thousand for the 6-month period ending 2011-11-27, per its 10-Q filed 2013-01-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent · last filed 2013-08-07
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for the quarter ending 2011-11-27 was $200.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for the quarter ending 2011-08-28 was $200.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for the quarter ending 2011-05-29 was $1.40M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for the quarter ending 2010-08-29 was -$200.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for fiscal 2011 was $800.00K, a 0.00% change from fiscal 2010.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in long-term receivables, current for fiscal 2010 was $800.00K.
| Period end | Increase (Decrease) in Long-term Receivables, Current 3 month | Increase (Decrease) in Long-term Receivables, Current 3 month as first filed | Increase (Decrease) in Long-term Receivables, Current 6 month | Increase (Decrease) in Long-term Receivables, Current 6 month as first filed | Increase (Decrease) in Long-term Receivables, Current 9 month | Increase (Decrease) in Long-term Receivables, Current 12 month |
|---|---|---|---|---|---|---|
| 2011-11-27 | $200.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $400.00K 10-Q · filed 2013-01-04 | -$400.00K 10-Q · filed 2012-01-05 | $1.80M derived: sum of 3 quarters · filed 2013-08-07 | ||
| 2011-08-28 | $200.00K 10-Q/A · filed 2013-01-02 | -$200.00K 10-Q · filed 2011-10-05 | $1.60M derived: sum of 2 quarters · filed 2013-08-07 | |||
| 2011-05-29 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $800.00K 10-K · filed 2013-08-07 | ||||
| 2011-02-27 | -$600.00K 10-Q · filed 2012-03-28 | |||||
| 2010-11-28 | -$400.00K 10-Q · filed 2012-01-05 | |||||
| 2010-08-29 | -$200.00K 10-Q · filed 2011-10-05 | |||||
| 2010-05-30 | $800.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |